Abstract
Objective:
To evaluate the effect of low-dose heparin on duration of peripherally inserted percutaneous central venous catheter (PCVC) patency and catheter occlusion.
Study Design:
Our research was a prospective, randomized, controlled, double-blind clinical study including 246 eligible neonates with PCVCs. It was conducted at the neonatal intensive care unit (NICU) of Diyarbakir Children's Hospital between 1 February 2007 and 31 October 2008. In the heparin group (n=118), the total parenteral nutrition (TPN) solutions contained heparin, which was infused at a rate of 0.5 IU kg−1 h−1. The no-heparin group (n=121) received TPN fluids without heparin.
Result:
In the heparin group, the duration of catheter patency was longer than that of the no-heparin group reaching a statistically significant difference (12.4±4.5 vs 9.7±4.0, P<0.0001). In the heparin group, the proportion of patients completing the TPN therapy successfully was higher than in the no-heparin group (P=0.0001; relative risk (RR): 3.32 (95% confidence interval (CI): 1.92 to 5.73)) also demonstrating a statistically significant difference. The rate of catheter occlusion among infants in the heparin group was smaller (P=0.0001; RR: 3.44 (95% CI: 1.92 to 6.44)). There were no statistically significant differences between the two groups in the incidence of other catheter-related problems. The length of the occluded catheter outside the skin, TPN infusion rate and catheter duration time were found to be the factors associated with catheter occlusion. Heparin prevented catheter occlusion with a mechanism unrelated to these factors.
Conclusion:
In neonates with PCVCs, low-dose continuous infusion of heparin (0.5 IU kg−1 h−1) within TPN fluids is an effective measure in terms of reducing catheter occlusion, allowing successful completion of the therapy, without increasing adverse effects. Furthermore, this effect of heparin may occur independently via occlusion-related factors that we evaluated in the study.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Graham DR, Keldermans MM, Klemm LW, Semenza NJ, Shafer ML . Infectious complications among patients receiving home intravenous therapy with peripheral, central, or peripherally placed central venous catheters. Am J Med 1991; 16 (91): 95–100.
Tager IB, Ginsberg MB, Ellis SE, Walsh NE, Dupont I, Simchen E et al. An epidemiologic study of the risks associated with peripheral intravenous catheters. Am J Epidemiol 1983; 118 (6): 839–851.
Schlesinger AE, Braverman RM, DiPietro MA . Pictorial essay. Neonates and umbilical venous catheters: normal appearance, anomalous positions, complications, and potential aid to diagnosis. AJR 2003; 180 (4): 1147–1153.
Infusion Nurses Society. Infusion nursing standards of practice. J Intraven Nurs 2006; 29 (Suppl 1S): S1–292.
Lawson M, Bottino JC, McCredie KB . Long-term I.V. therapy: a new approach. AJN 1979; 79 (6): 1100–1103.
Shaw JCL . Parenteral nutrition in the management of sick low birth weight infants. Pediatr Clin North Am 1973; 20: 333–358.
Pettit J, Wyckoff MM . NANN (National Association of Neonatal Nurses) Peripherally Inserted Central Catheters. Guideline for Practice, 2nd edn National Association of Neonatal Nurses: Glenview, IL, 2007.
Goutail-Flaud MF, Sfez M, Berg A, Laguenie G, Couturier C, Barbotin-Larrieu F et al. Central venous catheter-related complications in newborns and infants: a 587-case survey. J Pediatr Surg 1991; 26 (6): 645–650.
Schiff DE, Stonestreet BS . Central venous catheters in low birth weight infants: incidence of related complications. J Perinatol 1993; 13 (2): 153–158.
Shah PS, Shah VS . Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database Syst Rev 2008; (2): CD002772.
Kamala F, Boo NY, Cheah FC, Birinder K . Randomized controlled trial of heparin for prevention of blockage of peripherally inserted central catheters in neonates. Acta Paediatr 2002; 91 (12): 1350–1356.
Shah PS, Kalyn A, Satodia P, Dunn MS, Parvez B, Daneman A et al. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (heparin infusion for PCVC) study. Pediatrics 2007; 119 (1): 284–291.
Papile LA, Burstein J, Burstein R, Koffler H . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 gm. J Pediatr 1978; 92: 529–534.
Treas LS, Latinis-Bridges B . Efficacy of heparin in peripheral venous infusion in neonates. J Obstet Gynecol Neonatal Nurs 1992; 21 (3): 214–219.
Klenner AF, Fusch C, Rakow A, Kadow I, Beyersdorff E, Eichler P et al. Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial. J Pediatr 2003; 143 (6): 741–745.
de Neef M, Heijboer H, van Woensel JB, de Haan RJ . The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial. Pediatr Hematol Oncol 2002; 19 (8): 553–560.
Del Cotillo M, Grané N, Llavoré M, Quintana S . Heparinized solution vs saline solution in the maintenance of arterial catheters: a double blind randomized clinical trial. Intensive Care Med 2008; 34: 339–343.
Ruggiero RP, Aisenstein TJ . Central catheter fibrin sleeve-heparin effect. JPEN J Parenter Enteral Nutr 1983; 7 (3): 270–273.
Nakamura KT, Sato Y, Erenberg A . Evaluation of a percutaneously placed 27-gauge central catheter in neonates weighing less than 1200 grams. JPEN J Parenter Enteral Nutr 1990; 14: 295–299.
Krzywda EA . Central venous access—catheters, technology, and physiology. Medsurg Nurs 1998; 7 (3): 132–139.
Wickham R, Purl S, Welker D . Long term central venous catheters: issues for care. Semin Oncol Nurs 992; 8 (2): 133–147.
Di Costanzo J, Sastre B, Choux R, Reynier JP, Noirclerc M, Cano N et al. Experimental approach to prevention of catheter-related central venous thrombosis. JPEN J Parenter Enteral Nutr 1984; 8: 293–297.
Paauw JD, Borders H, Ingalls N, Boomstra S, Lambke S, Fedeson B et al. The incidence of PICC line-associated thrombosis with and without the use of prophylactic anticoagulants. JPEN J Parenter Enteral Nutr 2008; 32 (4): 443–447.
Randolph AG, Cook DJ, Gonzales CA, Andrew M . Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomized controlled trials. Br Med J 1998; 316: 969–975.
Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M et al. Heparin-induced trombocytopenia in patients treated with low molecular-weight heparin or unfractioned heparin. N Engl J Med 1995; 332 (20): 1330–1335.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Uslu, S., Ozdemir, H., Comert, S. et al. The effect of low-dose heparin on maintaining peripherally inserted percutaneous central venous catheters in neonates. J Perinatol 30, 794–799 (2010). https://doi.org/10.1038/jp.2010.46
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2010.46
Keywords
This article is cited by
-
Use of ranitidine is associated with infections in newborns hospitalized in a neonatal intensive care unit: a cohort study
BMC Infectious Diseases (2017)
-
Peripherally inserted central venous catheters: frequency of complications in premature newborn depends on the insertion site
Journal of Perinatology (2014)
-
Effect of heparin and other factors associated with complications of peripherally inserted central venous catheters in neonates
Journal of Perinatology (2012)